Pages that link to "Q36183417"

The following pages link to Vaccination against enterotoxigenic Escherichia coli, a cause of travelers' diarrhea (Q36183417):

Displaying 46 items.

• Vaccines for preventing enterotoxigenic Escherichia coli (ETEC) diarrhoea (Q24201328) (← links)
• Vaccines for preventing enterotoxigenic Escherichia coli (ETEC) diarrhoea (Q24236078) (← links)
• Clinical implications of enteroadherent Escherichia coli (Q26865925) (← links)
• Crystal structure of the full-length ATPase GspE from the Vibrio vulnificus type II secretion system in complex with the cytoplasmic domain of GspL (Q27684938) (← links)
• Transcutaneous immunization with heat-labile enterotoxin: development of a needle-free vaccine patch (Q28252883) (← links)
• Vaccination strategies to combat an infectious globe: oral cholera vaccines. (Q33900135) (← links)
• Secretory IgA-mediated protection against V. cholerae and heat-labile enterotoxin-producing enterotoxigenic Escherichia coli by rice-based vaccine (Q33928456) (← links)
• Bile acids improve the antimicrobial effect of rifaximin (Q34108534) (← links)
• Status of vaccine research and development for enterotoxigenic Escherichia coli (Q34518700) (← links)
• Vaccines against traveler's diarrhoea and rotavirus disease - a review. (Q34572829) (← links)
• Safety and immunogenicity of escalating dosages of a single oral administration of peru-15 pCTB, a candidate live, attenuated vaccine against enterotoxigenic Escherichia coli and Vibrio cholerae (Q34784973) (← links)
• Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial. (Q34786549) (← links)
• Vaccination with Dukoral against travelers' diarrhea (ETEC) and cholera (Q34787413) (← links)
• Context-dependent activation kinetics elicited by soluble versus outer membrane vesicle-associated heat-labile enterotoxin. (Q35191960) (← links)
• A combination vaccine consisting of three live attenuated enterotoxigenic Escherichia coli strains expressing a range of colonization factors and heat-labile toxin subunit B is well tolerated and immunogenic in a placebo-controlled double-blind phas (Q35598235) (← links)
• Safety and immunogenicity of an enterotoxigenic Escherichia coli vaccine patch containing heat-labile toxin: use of skin pretreatment to disrupt the stratum corneum (Q35784104) (← links)
• Identification of Novel Components Influencing Colonization Factor Antigen I Expression in Enterotoxigenic Escherichia coli (Q35827432) (← links)
• Development of safe, effective and immunogenic vaccine candidate for diarrheagenic Escherichia coli main pathotypes in a mouse model (Q35918800) (← links)
• Rifaximin: a review of its use in the management of traveller's diarrhoea (Q36214684) (← links)
• Oral cholera vaccines: use in clinical practice (Q36489754) (← links)
• The oral, live attenuated enterotoxigenic Escherichia coli vaccine ACE527 reduces the incidence and severity of diarrhea in a human challenge model of diarrheal disease (Q36505159) (← links)
• The true burden and risk of cholera: implications for prevention and control (Q36856016) (← links)
• Safety and immunogenicity of a single oral dose of recombinant double mutant heat-labile toxin derived from enterotoxigenic Escherichia coli (Q37335500) (← links)
• Toxin-mediated effects on the innate mucosal defenses: implications for enteric vaccines (Q37593785) (← links)
• Travellers' diarrhoea - pros and cons of different prophylactic measures (Q37633392) (← links)
• Antigen-specific memory B-cell responses to enterotoxigenic Escherichia coli infection in Bangladeshi adults (Q37721929) (← links)
• A systematic review of ETEC epidemiology focusing on colonization factor and toxin expression (Q37896946) (← links)
• Infection strategies of enteric pathogenic Escherichia coli (Q38007348) (← links)
• Progress and hurdles in the development of vaccines against enterotoxigenic Escherichia coli in humans (Q38032878) (← links)
• Genome Sequence of Enterotoxigenic Escherichia coli Strain B2C. (Q38704559) (← links)
• Foodborne enterotoxigenic Escherichia coli: from gut pathogenesis to new preventive strategies involving probiotics (Q38781919) (← links)
• Binding of CFA/I Pili of Enterotoxigenic Escherichia coli to Asialo-GM1 Is Mediated by the Minor Pilin CfaE (Q38895273) (← links)
• Efficacy and safety of a patch vaccine containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase 3, randomised, double-blind, placebo-controlled field trial in travellers from Europe to Mexico and Guatemala (Q38900076) (← links)
• Characterization of Mucosal Immune Responses to Enterotoxigenic Escherichia coli Vaccine Antigens in a Human Challenge Model: Response Profiles after Primary Infection and Homologous Rechallenge with Strain H10407 (Q38941412) (← links)
• Colonization Factors in Enterotoxigenic Escherichia coli Strains in Travelers to Mexico, Guatemala, and India Compared with Children in Houston, Texas (Q40375701) (← links)
• Occurrence of virulence gene signatures associated with diarrhoeagenic and non-diarrhoeagenic pathovars of Escherichia coli isolates from some selected rivers in South-Western Nigeria (Q41070016) (← links)
• Draft Whole-Genome Sequences of 10 Enterotoxigenic Escherichia coli Serogroup O6 Strains (Q41868446) (← links)
• A commensal gone bad: complete genome sequence of the prototypical enterotoxigenic Escherichia coli strain H10407. (Q42033890) (← links)
• Effectiveness and economic analysis of the whole cell/recombinant B subunit (WC/rbs) inactivated oral cholera vaccine in the prevention of traveller's diarrhoea. (Q42224513) (← links)
• Draft Whole-Genome Sequences of 10 Serogroup O6 Enterotoxigenic Escherichia coli Strains (Q43072089) (← links)
• Construction and preclinical evaluation of recombinant Peru-15 expressing high levels of the cholera toxin B subunit as a vaccine against enterotoxigenic Escherichia coli (Q50854404) (← links)
• Transcutaneous immunization with the heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC): protective efficacy in a double-blind, placebo-controlled challenge study. (Q55043303) (← links)
• Immunogenicity of enterotoxigenic Escherichia coli outer membrane vesicles encapsulated in chitosan nanoparticles. (Q55255574) (← links)
• Impfstoffe gegen Durchfallserkrankungen – am Beispiel der Impfstoffe gegen Reisediarrhoe und gegen Rotavirus (Q57029745) (← links)
• Expression of enterotoxigenic Escherichia coli colonization factors in Vibrio cholerae (Q64449334) (← links)
• Treated wastewater used in fresh produce irrigation in Nsukka, Southeast Nigeria is a reservoir of enterotoxigenic and multidrug-resistant Escherichia coli (Q94565064) (← links)